Information for COVID-19 Therapeutics Providers

Texas Case Counts microscopic example of a coronavirus

This page contains information and resources for Texas COVID-19 therapeutics providers. Providers with questions can contact or call Provider Support at 833‑832‑7068, option 0.

On this page:

News & Updates

Update on Therapeutics and the Omicron Variant

See the 1/20/22 DSHS letter to therapeutics providers for an update on COVID-19 therapeutics and the Omicron variant.

More Provider Notices

Weekly eDigests (PDFs)

How to Become a COVID-19 Therapeutics Provider

To order COVID-19 therapeutics, providers must have an AmerisourceBergen Account and have access to the Vaccine Allocation Ordering System (VAOS).

For more information on the enrollment process, please review the COVID-19 Therapeutics Enrollment Guide (PDF).

If you have any questions or issues, please email or call Provider Support at 833‑832‑7068, option 0.

Therapeutics Products

Click on any of the buttons below to access a list of product-specific resources.

For the latest information on product distribution across the state, see the Texas COVID-19 Product Availability section.

Monoclonal Antibody (mAb) Products

Bamlanivimab + Etesevimab (Lilly) Casirivimab + Imdevimab (Regeneron) Sotrovimab (GlaxoSmithKline)

Long-Acting Antibody (LAAB) Product

Evusheld: tixagevimab + cilgavimab (AstraZeneca)

Oral Antiviral Products

Molnupiravir (Merck) Paxlovid: nirmatrelvir + ritonavir (Pfizer)

Provider Resources & Training

Important Links

Job Aids & FAQs


Texas COVID-19 Product Availability

Billing & Coding Information

▲ Top

This page is being updated as new information becomes available.

Last updated January 21, 2022